Shares of network testing solutions company Viavi Solutions (NASDAQ:VIAV) jumped 7.6% in the afternoon session after the company launched a new network security product and received a significant price target increase from an analyst.

Shares of digital advertising platform The Trade Desk (NASDAQ:TTD) fell 5.9% in the afternoon session after the stock continued to pull back as reports revealed that Publicis informed its clients to avoid the ad-tech platform following an audit report tha

Ovid stock surged 18% following positive Phase 1 data for OV329, and investors are getting excited about a forthcoming Phase 2.

Shares of cloud security and performance company Cloudflare (NYSE:NET) jumped 3.4% in the afternoon session after reports revealed that Coinbase is planning to use Cloudflare’s infrastructure for stablecoin-based AI agent payments.

GigaCloud Technology, a global B2B ecommerce platform for large goods, reported significant insider selling in its latest SEC filing.

Shares of materials and photonics company Coherent (NYSE:COHR) jumped 6.9% in the afternoon session after Stifel raised its price target on the stock, citing the company's strong position to benefit from the buildout of AI datacenters.

Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 5.4% in the afternoon session after Mizuho raised its price target on the shares following the company's recent Investor Day.

These two companies are benefiting significantly from growing adoption of custom artificial intelligence (AI) processors by hyperscalers and AI companies.

Wall Street anticipated the Fed's decision to hold rates steady on Wednesday.

Shares of pool products retailer Leslie’s (NASDAQ:LESL) jumped 11.2% in the afternoon session after a company director acquired 7,281 shares of common stock.

Micron's business has been soaring due to strong demand for its storage and memory products.

Investors often scoff at the stock's premium price tag. But if there's any business that deserves such a high valuation multiple, it's this one.

Shares of natural food company Hain Celestial (NASDAQ:HAIN) fell 5.9% in the afternoon session after Barclays downgraded the stock to Underweight from Equal Weight.

Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.

The chief executive just provided a stunning forecast for the company's future growth.